Preparation and Evaluation of Minoxidil Gels for Topical Application in Alopecia

نویسندگان

  • M. SREENIVASA
  • VEERABHADRA RAO
چکیده

In the present study four minoxidil gels were prepared using carbopol, hydroxypropyl cellulose, hydroxypropyl methylcellulose and combination of hydroxypropyl cellulose, hydroxypropyl methylcellulose for the treatment of alopecia. The gels were evaluated for drug content, viscosity determination, in vitro permeation (across dialysis membrane and mouse skin), skin irritation and stability at 4, 25 and 37° tests. The drug content of the gels was found to range from 96.40±0.57 to 98.10±0.32%. The viscosity of the gels ranged between 13,780±100 and 24,950±150 cps. The drug permeation across dialysis membrane from all the formulations at the end of 24 h was almost same and ranged between 92.05±1.52 and 93.52±1.95%. Although the difference is insignificant, the percentage release of drug was found to increase in the following order of the polymer composition: HPC>Carbopol>HPMC>HPMC+HPC. All the gel formulations released almost similar amounts of drug (90.05±1.92 to 91.56±1.65%) across the mouse skin; but the cumulative amount of drug permeated across dialysis membrane was more than that of the mouse skin. The marketed topical solution was found to diffuse almost 100% of drug across dialysis membrane and mouse skin at the end of 12 h. As supported by Higuchi’s equation, the drug release mechanism from all the gels was found to be diffusion dominated. The prepared gels did not produce any dermatological reactions and were well tolerated by the mice. The gels were found to be stable with respect to viscosity, drug content and physical appearance at all temperature conditions for 3 months.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

مقایسه‌ی اثربخشی مینوکسیدیل نیوزومال با مینوکسیدیل متداول در درمان آلوپسی آندروژنتیک در مردان:کارآزمایی بالینی تصادفی دارای گروه شاهد و دوسوکور

Background and Aim: Androgenetic alopecia (AGA) is the most common type of alopecia in men. Currently, minoxidil is the only topical drug which has been approved by FDA for the treatment of AGA. However, its efficacy is restricted because of its low skin penetration. Since vesicular systems such as liposomes and niosomes have higher efficacy and lower adverse effects, this study was conducted t...

متن کامل

ارزیابی بی‌خطری محلول موضعی مینوکسیدیل 5% + بابونه‌ی 7%

Background and Aim: Androgenetic alopecia (AGA) is the most common form of alopecia in men, worldwide and topical minoxidil appears to be the most effective and safe treatment for AGA beside oral finasteride. Safety assessment of topical minoxidil formulation could be conducted using in vivo studies on human volunteers. Using skin biophysical parameters is a fast and noninvasive method for safe...

متن کامل

Therapeutic Effects of Topical Minoxidil or Rosemary and the Combination of Both on the treatment of Alopecia areata

Background & Objectives: Considering the prevalence of Alopecia areata, , failure of treatment, and the unknown pathogenesis of this illness, a comparative study was performed by using topical Minoxidil 2% and topical rosemary solution alone and in combination to treatment this disease. Materials & Methods: This study is a clinical trial performed on 200 patients with Alopecia areata referri...

متن کامل

Formulation and Evaluation of Hydrogel-Thickened Microemulsion For Topical Delivery of Minoxidil

The available minoxidil formulations for topical application suffer with major drawback and requires repeated application. The present study was aimed to investigate the effect of microemulsions and microemulsion based hydrogel-systems (MEHs) for increased percutaneous penetration of minoxidil. Minoxidil microemulsions were developed by conventional titration method using oleic-acid as oil, twe...

متن کامل

Minoxidil in combination with Tretinoin vs. Minoxidil in the treatment of male androgenic alopecia: A randomized, double-blind, parallel clinical trial

Background: Minoxidil is currently an approved treatment for androgenetic alopecia. Topical tretinoin can enhance skin absorption of minoxidil. Objective: This study has been done in order to determine the efficacy and safety of the solution of 0.5% minoxidil+0.05% tretinoin compared to 2% minoxidil in androgenetic alopecia in men. Patients and Methods: In a randomized, double-blind, parallel-g...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2006